Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

International Bio service

ClinicalTrials.gov lists International Bio service as lead sponsor of 12 trials.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Latest dated events Latest dated events 12 Biomarker capability evidence Biomarker capability evidence 86 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Latest dated events Latest dated events 12 Biomarker capability evidence Biomarker capability evidence 86

Rows recorded per section (log scale)

21 sections measured, none recorded

This page covers International Bio service: 12 lead-sponsored trials and 0 legal-entity registrations.

Get the International Bio service report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by start year as sponsor or collaborator (1)

Trials by start year as sponsor or collaborator
Year Trials started
2024 12

No forecast is made for this organization: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 12 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Latest dated events (12)

Shown in this order: newest first.

Latest dated events
Date Event Source
2024-09-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-09-23 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-08-26 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-08-13 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-07-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 12 events.

Start your 14-day trial Email me all 12 events as a PDF

Biomarker capability evidence (86)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ALB Trial sponsor Named in trial exclusion criteria
CYP3A4 Trial sponsor Named in trial exclusion criteria
CYP3A4 Trial sponsor Named in trial exclusion criteria
EGFR Trial sponsor Named in trial exclusion criteria
EGFR Trial sponsor Named in trial exclusion criteria

Showing 5 of 86 evidence rows.

Start your 14-day trial Email me the first 50 evidence rows as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, disease areas, active development programs, approved assets, sponsor delivery record, journals published in, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.